CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression. - Wikidata - wikimedia - TriplyDB

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

http://www.wikidata.org/entity/Q34786582

about

The role of CD44 in epithelial-mesenchymal transition and cancer development GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancer Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.Biomarkers for EMT and MET in breast cancer: An update.Mixed lineage kinase ZAK promotes epithelial-mesenchymal transition in cancer progression.Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion.

P2860

Q26771509-6AA1C70B-7CE8-48D0-9999-A4856C0E7809 Q34465040-72C7F0A4-3CD7-433A-B76C-BE2AD17CB082 Q35176048-74D3B73F-ADF4-4574-876B-C414FA30CF2B Q36546731-66D3E824-99C0-4220-A936-8E99BA5B8DE1 Q38745611-67539AE8-56E4-4F60-8B5D-7602CE6E9528 Q39095878-83066645-CF7F-41A4-A26E-A4BF3069A830 Q49358422-8C952968-E8C6-4287-8390-918A1E32EEF4 Q54978458-E6CE6E3F-9000-468F-A346-DE5E43289D2D

P2860

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

http://www.wikidata.org/entity/Q34786582

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@ast

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@en

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@nl

type

label

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@ast

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@en

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@nl

prefLabel

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@ast

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@en

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@nl

P1433

Q34786582-C7F79FE6-47AB-41A4-98E4-FFC9FADF25B2

P1476

Q34786582-928160F9-AACB-4AED-BA75-2C6B3C8E7BC6

P2093

Q34786582-4BFBEDB6-B62A-4C37-8A04-735D73CD584F

Q34786582-5FAA4CC0-E3CD-4FBF-92B2-520BB22E173A

Q34786582-A29B0CA2-8823-4DBB-9460-08806DF6C40B

Q34786582-B73604BD-11AE-4D1E-BE37-C5FC89C7966E

Q34786582-D6FE1C8F-A7B5-45CF-B594-26570F4B7D5B

Q34786582-EED2BCC4-D415-4A57-9C4C-587FA6615C44

P2860

Q34786582-0A602ED6-4CC2-4221-AB2F-95DAC3C741E4

Q34786582-0C2C1B2D-93B1-4A59-8264-42BFDAB5BDAD

Q34786582-1A52F6DE-E15C-4567-9F0C-A36B49D879A1

Q34786582-274AC538-048F-4334-802C-D2A4ECCB4692

Q34786582-2753B5FE-381A-4B16-A493-8A6D87956048

Q34786582-2ADA4D8E-16FE-4517-880B-E7AB15E977BD

Q34786582-2CB6D463-CE8E-49B1-BAAF-D5A55F575EC2

Q34786582-35576F60-344D-4BCA-AE57-AB9C25D32C40

Q34786582-3639F7A4-9291-4317-9AE4-1561D6576041

Q34786582-3CDCC7EA-3A9F-4CC4-8D95-26FDDE9270DA

P304

Q34786582-658BD04D-6375-4F66-AD2C-C4CD4E735495

P31

Q34786582-221ACE4C-1AB9-4427-ADAD-C5C1D2E5BDB7

P356

Q34786582-3B1614FD-5755-47F9-81F6-1CB964D3AE0B

P407

Q34786582-C7E2A22B-70D8-4DA4-AE60-A90B4C6606AF

P433

Q34786582-AA58B1D9-82A8-4BBF-ABAD-494C79123CB6

P478

Q34786582-C55A4E8F-6D74-42DB-A159-AE00561872A3

P577

Q34786582-34378FC2-9A8A-4137-9B42-183B12AA1862

P698

Q34786582-8979268C-8AEE-4B6C-A1C1-9E462A71FA2A

P932

Q34786582-DCCE5EA1-2BAA-49AC-B479-B988F73B0101

P356

ONCOTARGET.2535

P1433

P1476

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

@en

P2093

Chunping Liu

http://www.w3.org/2001/XMLSchema#string

Guangwei Du

http://www.w3.org/2001/XMLSchema#string

Jeffrey T Chang

http://www.w3.org/2001/XMLSchema#string

Linna Li

http://www.w3.org/2001/XMLSchema#string

Robert J Amato

http://www.w3.org/2001/XMLSchema#string

Wenliang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE

The protein kinase complement of the human genome

Autocrine PDGFR signaling promotes mammary cancer metastasis

Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells

Comprehensive molecular portraits of human breast tumours

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Prospective identification of tumorigenic breast cancer cells

An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype

P304

10840-10853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2535

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25333262

http://www.w3.org/2001/XMLSchema#string

P932

4279414

http://www.w3.org/2001/XMLSchema#string